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Abstract Since the adhesion of bacteria to the tooth
surface is a prerequisite for dental plaque and subsequent
caries development, a promising caries preventive strategy
could be to block the lectin–glycan-mediated adherence of
cariogenic bacteria. The aim of the study was to evaluate
potential differences in glycan-binding specificities of two
Streptococcus mutans strains (DSM 20523 and DSM 6178)
and Streptococcus sobrinus (DSM 20381). A competitive
enzyme-linked lectin-binding assay was used to identify
the binding specificities of isolated bacterial surface lectins.
Blotting of the microbial proteins on neoglycoprotein-coated
PVP membranes enabled a qualitative protein analysis of all
specific bacterial lectins. Different glycan-binding sites could
be identified for the S. mutans strains in comparison to S.
sobrinus. An earlier reported glycan-binding specificity
for terminal galactose residues could be confirmed for
the S. mutans strains. For the S. sobrinus strain, more than
one glycan-binding specificity could be found (oligomannose
and terminal sialyl residues). Each of the tested strains
showed more than one surface lectin responsible for
the specific lectin-binding with varying molecular weight
(S. mutans, 90/155 kDa and S. sobrinus, 35/45 kDa). The
established experimental setup could be used as future
standard procedure for the identification of bacterial lectin-
derived binding specificities. The findings from this study
might serve as basis for the design of an individual ‘glycan
cocktail’ for the competitive inhibition of lectin-mediated
adhesion of mutans streptococci to oral surfaces.
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Introduction
Several microorganisms have been identified from carious
lesions of which Streptococcus mutans and Streptococcus
sobrinus are the most prevalent pathogenic species in
humans involved in the initiation and development of
dental caries [1–4]. The high cariogenic potential especially
of S. mutans derives from the ability to produce high
amounts of organic acid and extracellular glycans in the
presence of low molecular sugars [3, 5, 6].
Consequently, established preventive strategies such as
dietary control, topical or systemic use of fluorides and fissure
sealants have led to a significant caries decline [7, 8].
However, caries is still causing high costs in health systems.
Due to the current stagnation within caries prevention [9],
continuing development of innovative preventive strategies
and techniques seems to be indispensable to minimize
further expansion of this widespread disease.
Since the adhesion of bacteria to the tooth surface
represents the initial step in the pathogenesis of dental
plaque formation and subsequent caries development [10],
an anti-adhesive therapy gains significant importance by a
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possible prevention of specific lectin-mediated adherence
mechanisms [11–13]. Studies concentrating on salivary
glycans have indicated that specific soluble glycoconju-
gates in sufficient concentrations have the ability to
competitively inhibit the adherence of bacterial lectins of
caries-inducing microorganisms to immobilized glycocon-
jugates on oral surfaces [14, 15]. Thus, the aim of this study
was to evaluate potential differences in glycan-binding
specificities of two S. mutans strains and S. sobrinus.
Materials and methods
Both S. mutans strains (DSM 20523 and DSM 6178) and S.
sobrinus (DSM 20381) were obtained in lyophilisated form
by the DSMZ (Deutsche Sammlung von Mikroorganismen
und Zellkulturen, Braunschweig, Germany). Individual
colonies of each strain were cultivated in universal broth
agar (CASO-Bouillon, heipha, D-Eppelheim) within 1 week.
The resulting bacterial suspensions were each biotinylated
(0.5 mg Sulfo-NHS-LC-Biotin per millilitre reaction volume,
solved in 50 mM Na2CO3 buffer, pH 8.0), lysed (five times,
50 ml lysing buffer, pH 8.0, 10 min, 5,000 rpm) and finally
filtrated (PES filter 0.2 μm/10 kDa, Vivaflow 50, Vivascience,
Göttingen, Germany/10 kDa palfiltrons, Amicon® Ultra-4,
Millipore, Billerica, MA, USA) in order to obtain bacterial
homogenates >10 kDa, <0.2 μl, including their biotinylated
surface membrane proteins of lectin type. The BCA™ Protein
Assay-Kit (Pierce, Rockford, IL, USA) was used to adjust all
bacterial homogenates to the same total protein concentration.
A competitive enzyme-linked lectin-binding inhibition
assay was used to determine the binding specificity of
bacterial surface lectin-like adhesins towards lectin-specific
glycan patterns, as well as the potential binding inhibition by
soluble complementary glycans in dependence on their
concentration (Fig. 1). Based on the principle of the
competitive lectin-binding inhibition assay described by
Kage et al. [16], several microtitre plates were pre-coated
with immobilized neoglycoproteins (1:1,000, solved in
0.1 M Na2CO3 buffer, pH 8.5, 100 μl), with corresponding
binding specificities towards well-known lectins. The fol-
lowing purified plant and animal lectins with known
specificity for different glycan patterns were used in this
study: peanut agglutinin (PNA, specific for β-galacto-
1,3-N-acetyl-galactosamine, Sigma-Aldrich, Steinheim,
Germany), Galanthus nivalis agglutinin (GNA, specific
for terminal mannose residues, EY Laboratories Inc., San
Mateo, CA, USA), Concanavalin A (ConA, specific for
trimannosyl structures in high mannose type N-glycans,
Sigma-Aldrich, Steinheim, Germany), Sambucus nigra
agglutinin (SNA, specific for α-2,6-sialyl residues, EY
Laboratories Inc., San Mateo, CA, USA) and Anguilla
anguilla agglutinin (AAA, specific for α-1,6-fucose, EY
Laboratories Inc., San Mateo, CA, USA) [17]. The
following neoglycoproteins were used for pre-coating of the
microtitre plates: BSA-galactose-1,3-N-acetyl-galactosamine
(specific for PNA, Dextra Laboratories, Reading, UK), BSA-
α-mannopyranoside (specific for GNA and ConA, Sigma-
Aldrich, Steinheim, Germany), BSA-fucosylamide (specific
for AAA, Sigma-Aldrich, Steinheim, Germany) and fetuin
Fig. 1 Scheme of the competi-
tive lectin-binding inhibition
assay used to determine the
binding specificity of bacterial
surface lectin-like adhesins
towards lectin-specific glycan
patterns as well as the potential
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(specific for SNA, Sigma-Aldrich, Steinheim, Germany).
Unbound neoglycoproteins were removed during washing
(three times, 200 μl, 50 mM tris(hydroxymethyl)-amino-
methane, 0.1% Tween 20, pH 7.5) after overnight incubation
at 4°C. Subsequently, double rows on each microtitre plate
were incubated with 75 μl of the specific standard lectin
(1 mg/ml, 1:20,000 in probing buffer: 50 mM Tris–HCl,
150 mM NaCl, 0.1 mM MnCl2, 0.5 mM CaCl2, 2.0 mM
MgCl2, 0.025 mM ZnCl2, pH 7.5) and analogous all
bacterial homogenates (approximately 730 μg/ml, 1:1,500
in probing buffer, pH 7.5), each together with 25 μl soluble
complementary glycans (methyl-D-galactopyranoside (specific
for PNA, Sigma-Aldrich, Steinheim, Germany), mannan
(specific for GNA, Sigma-Aldrich, Steinheim, Germany),
α-L-(−)-fucose (specific for AAA, Sigma-Aldrich, Steinheim,
Germany), methyl-α-mannopyranoside (specific for ConA,
Sigma-Aldrich, Steinheim, Germany) andN-acetyl-neuramin-
lactose (specific for SNA, Dextra Laboratories, Reading,
UK) in different concentrations following a geometrically
dilution (in probing buffer, pH 7.5). Additionally, each
double row included a blank value to evaluate possible
unspecific bindings between buffer and immobilized neo-
glycoproteins, as well as the maximal lectin binding without
the addition of complementary soluble glycan. Finally, all
plates were incubated shaking for 30min at room temperature,
then overnight at 4°C. Washing (three times, 200 μl) allowed
the elimination of all unbound or by soluble complementary
glycans bound lectins. Only lectin molecules bound to the
immobilized glycoproteins were detected by the neutravidin
peroxidase detection system (100 μl, 1 mg/ml, 1:20,000 in
probing buffer) during a 1-h incubation at room temperature
(followed by a washing procedure, four times, 200 μl). The
colour change induced by tetramethylbenzidin substrate
(1:100 solved in galatti buffer, stopped with 50 μl 4 N
H2SO4) allowed finally the colorimetrically determination in
a spectral photometer (450 to 492 nm, Ultra 384, Tecan,
Crailsheim, Germany). Non-carbohydrate–lectin-specific
bindings between the lectins and the immobilized neo-
glycoproteins could be further measured by incubation with
the lectins in the presence of deglycosylated, immobilized
neoglycoproteins in the same experimental setup. In the
attempt to identify only the bacterial surface proteins
responsible for the lectin-mediated binding specificities,
deglycosylated glycoconjugates were obtained by using
oxidative separation of their terminal glycan structures.
Sodium dodecyl sulphate-polyacrylamide gel electro-
phoresis (SDS-PAGE) of the bacterial homogenates was
performed with a 10% polyacrylamide gel (CleanGel, 52S,
ETC, Kirchtellinsfurt, Germany) under reducing conditions
(10 μl 2.5 M DTT to 1 ml buffer). The gels were calibrated
with the following molecular weight standards: Precision
Plus (10–250 kDa, Bio-Rad, Hercules, CA, USA), pre-stained
Multi Mark (4–250 kDa, Invitrogen, Karlsruhe, Germany)
and biotinylated SDS Molecular Weight Standard (6.5–
180 kDa, Sigma-Aldrich, Steinheim, Germany). Silver stain-
ing (GE Healthcare Biosciences, Freiburg, Germany) enabled
to uncover all proteins of each bacterial homogenate separated
by their molecular weight. Based on the Western Blot
technique, a contact blot was newly developed to transfer
the SDS-PAGE separated proteins by diffusion to glycan-
specific polyvinyl difluoride (PVP) membranes (Fig. 2). The
glycan-specific PVP membranes were obtained by incuba-
tion (overnight at 4°C after activation with 100% methanol
for 10 min) with the same complementary glycoconjugates
used in the lectin assay described above. Both the PVP
membranes and the SDS gels were equilibrated in transfer
buffer (12 mM tris(hydroxymethyl)-aminomethane, 96 mM
glycine, 20% methanol) for 15 min. The PVP membranes
were then blotted under the weight of 5 kg in a blot
sandwich (lower glass plate–SDS gel–PVP-membrane–5×
filter paper–upper glass plate) for 1.5 h with the by
electrophoresis-separated microbial proteins. This technique
enabled a qualitative protein analysis of only the bacterial
lectins responsible for the specific binding to a specific
neoglycoprotein. After blocking remaining binding sites
(60 min at room temperature, 20 mM tris(hydroxymethyl)-
aminomethane, 137 mM NaCl, 2.0% Tween 20, pH 7.6) and
incubation with the neutravidin peroxidase detection system
(60 min, 1 mg/ml, 1:10,000 in probing buffer) followed by
Fig. 2 Scheme of the contact blot. SDS-PAGE-separated bacterial
proteins were blotted on glycan-specific polyvinyl difluoride (PVP)-
membranes enabling a qualitative protein analysis of only the bacterial
lectins responsible for a specific glycan binding. The following
glycans were used: methyl-D-galactopyranoside (specific for PNA),
mannan (specific for GNA), α-L-(−)-fucose (specific for AAA),
methyl-α-pyranoside (specific for ConA) and NAC-neuraminlactose
(specific for SNA). Using the neutravidin peroxidase detection system,
only the specific microbial biotinylated surface proteins could be
visualized by Enhanced Chemo-luminescence
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several washing steps (1×15 and 3×5 min, shaking in
washing buffer), the visualization of these specific proteins
was achieved by Enhanced Chemo-luminescence (solution 1
+2 mixed 1:1, 0.125 ml/cm2, Pharmacia Biotech, Piscat-
away, NJ, USA) onto a sensitive film (exposure time from
0.25 to 5 min, High Performance Chemiluminescence Film,
Amersham Biosciences). The exclusion of all non-
carbohydrate–lectin-based binding mechanisms was again
obtained by applying deglycosylated glycan patterns to the
PVP membranes in the same experimental setup using the
purified plant and animal lectins (PNA, GNA, ConA, SNA
and AAA) with the corresponding specificities as control.
Accordingly, to the competitive enzyme-linked lectin-
binding inhibition assay, all lectin-like adhesins with binding
specificities to the deglycosylated PVP membranes were
excluded from further consideration.
Results
All bacterial lectins showed a reproducible individual
binding behaviour with regard to the glycans tested.
Figure 3 illustrates the competitive binding inhibition by
different soluble complementary glycans towards the tested
bacterial strains S. mutans DSM 20523 and DSM 6178, as
well as S. sobrinus DSM 20381 in comparison to the
corresponding standard lectin with known specificity for
the tested glycans. Each purified standard lectin (PNA
(peanut agglutinin), GNA (G. nivalis agglutinin), ConA
(Concanavalin A), SNA (S. nigra agglutinin) and AAA (A.
anguilla agglutinin)) presents the typical graph of a
sigmoidal curve with a clear decrease of the lectin binding
(percent) to a rising concentration of the soluble comple-
mentary glycan. By using deglycosylated neoglycoproteins,
all identified non-lectin bindings between the bacterial
homogenates and the immobilized neoglycoproteins could
be excluded from further regards.
Earlier reported glycan-binding specificity for terminal
galactose residues could be confirmed for the two S. mutans
strains tested. Although minimal concentrations of the
soluble complementary glycan seem to be enough to inhibit
the lectin binding, differences appear in the degree of the
50% binding inhibition. While approximately 2.5 mM of
methyl-D-galactopyranoside was sufficient to reduce S.
mutans DSM 6178, approximately 5.0 mM was necessary
to evoke the 50% binding inhibition for S. mutans DSM
20523 (Fig. 3a). Additionally, the finding of a significant
mannose-binding specificity in the form of an oligomannose
of the S. sobrinus strain could be made. Figure 3b
demonstrates that only 0.1 μg/ml appears to be enough to
cause the 50% binding inhibition of the bacterial lectin
binding. Contrarily, branched mannose structures without
terminal mannose residues had no influence on the binding
specificity on none of the tested strains (Fig. 3c). Terminal
sialyl residues were shown to inhibit S. sobrinus as well. A
comparatively high amount of N-acetyl-galactosamine
(10 mg/ml) was needed for the 50% inhibition (Fig. 3d).
The specificity for terminal fucose could be excluded for all
tested mutans streptococci (Fig. 3e).
Blotting of the bacterial proteins separated by their
molecular weight onto glycan-specific PVP membranes
revealed more than one surface lectin responsible for the
specific lectin binding for each of the tested strains (Table 1
and Fig. 4). S. mutans DSM 20523 and DSM 6178 showed
PNA-specific surface lectins with varied molecular weights
of 90 and 155 kDa. S. sobrinus DSM 20381 showed GNA-
specific surface lectins of 35 and 45 kDa. Regarding the
SNA specificity of S. sobrinus DMS 20381, no clear
information can be given according to the molecular weight
of the corresponding surface lectin because of only slight
differences between the glycosylated and deglycosylated
PVP membranes (Fig. 4). A molecular weight around 25 to
35 kDa can be assumed; however, further verification is
needed.
Discussion
Long-term survival of bacteria in the oral cavity requires
that the microorganisms have the ability to adhere to a
tissue surface or colonize a suitable niche in the complex
biofilm. One of the many molecular mechanisms involved
in initial adherence of bacteria to the acquired pellicle and
subsequent development of mixed species oral biofilms is
the specific lectin–carbohydrate interaction between the
microorganisms and their host [12, 13].
Individual host defence factors of the saliva and crevicular
fluid protect the human organism to a certain degree of
accumulating or invading microorganisms. Besides the
systemic immune system, available soluble glycoconjugates
in saliva play an important role as a constitutional host defence
factor in terms of a first line of defence [14]. While promoting
the bacterial adhesion on the one hand, they can specifically
prevent the binding of bacteria by competitively blocking
their adhesion on the other hand [12, 18] depending on their
concentration available.
Whereas Zehetbauer et al. could not detect any significant
differences in the salivary protein profiles between children
with early childhood caries and caries-free children [19],
Seemann et al. found that salivary glycoconjugates of caries-
resistant children from a representative sample showed a
higher binding inhibition against the lectin PNA (specific for
terminal galactosyl residues) compared to saliva of caries-
susceptible children [15]. Studies concentrating on patients
with periodontal disease revealed a lack of terminal N-acetyl-
galactosamine residues, specific for Vicia villosa agglutinin
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[16]. Further research demonstrated a significant increase of
specific salivary glycoconjugates during a progressive
bacterial contamination in the oral cavity [20]. These data
indicate that a reduced availability of distinct glycosylation
patterns may act as an additional host-derived factor for an
increased occurrence of specific microorganisms within a
certain disease.
Anti-adhesion therapy aims the inhibition or complete
blocking of lectin-mediated adhesion with the intention to
reduce the initial adhesion of pathogenic microorganisms
on host tissues without affecting their viability to prevent
selective pressure and overgrowth of resistant bacteria. The
infection of the urothelium by Escherichia coli for instance
could be effectively inhibited after applying lectin-specific
methyl-α-D-mannopyranoside [21]. Consequently, this
model can be applied to the colonization of oral pathogens
such as cariogenic S. mutans and S. sobrinus in order to
prevent initial adhesion as a first step in the multi-factorial
caries aetiology. Although the lectin-mediated binding
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Fig. 3 Competitive binding inhibition of the bacterial homogenates
from Streptococcus mutans (DSM 20523), S. mutans (DSM 6178) and
Streptococcus sobrinus (DSM 20381) in the presence of soluble
glycans with PNA-specific glycan patterns (a), GNA-specific glycan
patterns (b), ConA-specific glycan patterns (c), SNA-specific glycan
patterns (d) and AAA-specific glycan patterns. (e) PNA peanut
agglutinin, GNA Galanthus nivalis agglutinin, ConA Concanavalin
A, SNA Sambucus nigra agglutinin, AAA Anguilla anguilla agglutinin
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well characterized yet, studies revealed that a high
molecular mass cranberry constituent was capable of
reducing mutans streptococci level in saliva and effectively
inhibiting in vitro adhesion to hydroxyapatite [22, 23].
Furthermore, studies in an artificial mouth model showed a
caries-preventive effect of an experimental glycan solution
prepared by hydrolysis of porcine gastric mucine on natural
teeth [24]. Early adhesion experiments by Gibbons and
Qureshi revealed that the adhesion of different S. mutans
serotypes to saliva-coated hydroxyapatite could be inhibited
by galactose and melibiose (6-α-D-galactosyl-glucose) but not
by lactose [25]. Further experiments by other investigators
supported the assumption that galactose residues seem to
have a significant meaning within the lectin-mediated
adhesion of S. mutans [26–28]. In the present study, these
findings could be confirmed for the two S. mutans strains
(DSM 20523 and DSM 6178) tested in the present study.
Nevertheless, terminal galactose residues had no influence
on the adherence of S. sobrinus DSM 20381, which supports
early observations that S. mutans and S. sobrinus attach to
different receptors in experimental pellicles [29]. Instead, S.
sobrinus showed a significant mannose-binding specificity in
Fig. 4 Overview of the different binding specificities of Streptococ-
cus mutans DSM 20523, S. mutans DSM 6178 and Streptococcus
sobrinus DSM 20381 regarding the molecular weights of their specific
bacterial surface lectins. For each tested strain, the proteins are
displayed in four columns, always in comparison to the Precision Plus
molecular weight standard (left column). While the total protein
identifies all verifiable proteins within the bacterial homogenate of
each strain (both from the surface and the bacterial inside), the
biotinylated column shows only the proteins of the bacterial surface
membrane with possible lectin specificity. Using glycosylated mem-
branes, only the bacterial surface proteins responsible for a specific
binding to a certain neoglycoprotein could be identified (PNA-specific
binding of S. mutans DSM 20523 and S. mutans DSM 6178, as well
as the GNA-/ConA-specific and SNA-specific binding of S. sobrinus
DSM 20381 could be found). By using deglycosylated membranes,
the bacterial surface proteins responsible for the lectin-mediated
binding specificities could be identified. Only the proteins marked
by the arrows bind on carbohydrate–lectin-mediated binding mech-
anisms (binding reduction because of the separation of the terminal
glycan structures of the neoglycoproteins). For each specific lectin-
binding of the tested strains, more than one surface lectin with varied
molecular weight could be identified (PNA-specific 90/155 kDa of S.
mutans DSM 20523 and S. mutans DSM 6178; GNA-/ConA-specific
35/45 kDa of S. sobrinus DSM 20381)
Table 1 Molecular weights of the specific bacterial surface lectins depending on their binding specificities
Binding specificities of the bacterial surface proteins (lectins) DSM 20523 DSM 6178 DSM 20381
β-galacto-1,3-N-acetyl-galactosamine (PNA-specific) 90 kDa 90 kDa –
155 kDa 155 kDa
Terminal mannose residues (GNA-specific) – – 35 kDa
45 kDa
Branched mannose residues (ConA-specific) – – –
α-2,6-Sialyl residues (SNA-specific) – – Further verification needed
α-1,6-Fucose (AAA-specific) – – –
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form of an oligomannose (GNA specific). Interestingly, a
branched monomannose structure without terminal mannose
residues (ConA specific) had no influence on the binding
specificity on the tested strains. The present results identified
another novel aspect of bacterial lectins: terminal sialyl
residues were also shown to inhibit S. sobrinus.
The comparable less distinctive binding inhibition of S.
sobrinus by sialyl residues may be explained by a
glycosylation pattern, which is very similar but does not
absolutely correspond to the lectin-binding specificity.
Respectively, it can be assumed that there are further surface
lectin-binding specifities available for S. mutans as well.
In all bacterial strains, we identified more than one
surface lectin (Fig. 4) capable of the specific lectin binding
with varied molecular weight (S. mutans, 90/155 kDa and
S. sobrinus, 35/45 kDa), which supports speculations that
epitopes necessary for a specific adherence can be found on
multiple proteins [30]. For SNA-specific binding of S.
sobrinus, a molecular weight of around 25 to 35 kDa can be
speculated, but further investigation is needed (Fig. 4 and
Table 1). Because of the heterogeneous binding behaviour of
caries-relevant microorganisms, anti-adhesive agents should
be adapted to the individual adhesion specificity. Further
studies concentrating on the revelation of the bacterial
surface lectin-binding specificities will elucidate the effec-
tiveness of glycoconjugates as anti-adherence agents.
Regarding the established experimental concept and
technique, this present in vitro study might be used as a
future standard procedure for the identification of the
individual binding specificity of predominant caries-
inducing microorganisms.
Conclusions
In conclusion, these findings suggest that mutans streptococci
possess surface lectins with heterogeneous glycan-binding
sites in order to adhere to oral surfaces. Different glycan-
binding sites could be identified for the S. mutans strains in
comparison to S. sobrinus. For the S. sobrinus strain, more
than one glycan-binding specificity could be detected. An
earlier reported glycan-binding specificity for terminal galac-
tose residues could be confirmed for the S. mutans strains.
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